Anna Grodzinsky1, Abhinav Goyal2, Kensey Gosch3, Peter A McCullough4, Gregg C Fonarow5, Alexandre Mebazaa6, Frederick A Masoudi7, John A Spertus8, Biff F Palmer9, Mikhail Kosiborod8. 1. Saint Luke's Mid America Heart Institute, Kansas City, Mo; University of Missouri-Kansas City. Electronic address: agrodzinsky@gmail.com. 2. Division of Cardiology, Emory Healthcare, and Emory School of Medicine, Atlanta, Ga. 3. Saint Luke's Mid America Heart Institute, Kansas City, Mo. 4. Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Tex; The Heart Hospital, Plano, Tex. 5. Division of Cardiology, University of California-Los Angeles. 6. Department of Anesthesia and Critical Care Medicine, Hôpitaux Universitaire, Saint Louis Lariboisière, University Paris Diderot, Sorbonne Paris Cité, Paris, France. 7. Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora. 8. Saint Luke's Mid America Heart Institute, Kansas City, Mo; University of Missouri-Kansas City. 9. Division of Nephrology, University of Texas Southwestern Medical Center, Dallas.
Abstract
BACKGROUND: Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. METHODS: In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. RESULTS: Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. CONCLUSIONS: Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
BACKGROUND:Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. METHODS: In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. RESULTS: Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. CONCLUSIONS:Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
Authors: Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg Journal: Clin J Am Soc Nephrol Date: 2010-07-01 Impact factor: 8.237
Authors: David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier Journal: N Engl J Med Date: 2004-08-05 Impact factor: 91.245
Authors: Jung Nam An; Jung Pyo Lee; Hee Jung Jeon; Do Hyoung Kim; Yun Kyu Oh; Yon Su Kim; Chun Soo Lim Journal: Crit Care Date: 2012-11-21 Impact factor: 9.097
Authors: Chanu Rhee; Zilu Zhang; Sameer S Kadri; David J Murphy; Greg S Martin; Elizabeth Overton; Christopher W Seymour; Derek C Angus; Raymund Dantes; Lauren Epstein; David Fram; Richard Schaaf; Rui Wang; Michael Klompas Journal: Crit Care Med Date: 2019-03 Impact factor: 7.598
Authors: Julia A Heneghan; Eduardo A Trujillo Rivera; Qing Zeng-Treitler; Farhana Faruqe; Hiroki Morizono; James E Bost; Murray M Pollack; Anita K Patel Journal: Pediatr Crit Care Med Date: 2020-09 Impact factor: 3.971
Authors: Benjamin Brueske; Mandeep S Sidhu; Joshua Schulman-Marcus; Kianoush B Kashani; Gregory W Barsness; Jacob C Jentzer Journal: J Am Heart Assoc Date: 2019-04-02 Impact factor: 5.501
Authors: Anita K Patel; Eduardo Trujillo-Rivera; Farhana Faruqe; Julia A Heneghan; T Elizabeth Workman; Qing Zeng-Treitler; James Chamberlain; Hiroki Morizono; Dongkyu Kim; James E Bost; Murray M Pollack Journal: Pediatr Crit Care Med Date: 2020-09 Impact factor: 3.971
Authors: Zubaid Rafique; Mikhail Kosiborod; Carol L Clark; Adam J Singer; Stewart Turner; Joseph Miller; Douglas Char; W Frank Peacock Journal: Clin Exp Emerg Med Date: 2017-09-30
Authors: Alessandro Gasparini; Marie Evans; Peter Barany; Hairong Xu; Tomas Jernberg; Johan Ärnlöv; Lars H Lund; Juan-Jesús Carrero Journal: Nephrol Dial Transplant Date: 2019-09-01 Impact factor: 5.992